Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

ESR2 gene linked to female-pattern hair loss.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Regulating certain sex hormones may help delay facial aging.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.